Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Hypersensitivity Reaction

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 28 articles:
HTML format



Single Articles


    October 2025
  1. MARWAH H, Ramsey A, Macy EM
    Allergy or Assumption of Allergy - When to Test for a Penicillin Allergy.
    N Engl J Med. 2025;393:1340-1342.
    PubMed    


    July 2025
  2. KAHLMANN V, Janssen Bonas M, Moor CC, Grutters JC, et al
    First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate.
    N Engl J Med. 2025;393:231-242.
    PubMed     Abstract available


    May 2025
  3. LAFORCE C, Albers F, Danilewicz A, Jeynes-Ellis A, et al
    As-Needed Albuterol-Budesonide in Mild Asthma.
    N Engl J Med. 2025 May 19. doi: 10.1056/NEJMoa2504544.
    PubMed     Abstract available


    March 2025
  4. METZ M, Gimenez-Arnau A, Hide M, Lebwohl M, et al
    Remibrutinib in Chronic Spontaneous Urticaria.
    N Engl J Med. 2025;392:984-994.
    PubMed     Abstract available


    January 2025
  5. COHN DM, Gurugama P, Magerl M, Katelaris CH, et al
    CRISPR-Based Therapy for Hereditary Angioedema.
    N Engl J Med. 2025;392:458-467.
    PubMed     Abstract available


    September 2024
  6. ROTHENBERG ME, Dellon ES, Collins MH
    Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis. Reply.
    N Engl J Med. 2024;391:1067-1068.
    PubMed    


  7. CHEHADE M, Dellon ES, Spergel JM
    Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis. Reply.
    N Engl J Med. 2024;391:1066-1067.
    PubMed    


  8. MENNINI M, Parisi P, Di Nardo G
    Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis.
    N Engl J Med. 2024;391:1066.
    PubMed    


  9. LIN CH
    Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis.
    N Engl J Med. 2024;391:1065-1066.
    PubMed    


  10. CHAO CY, Chao HH, Yong SB
    Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis.
    N Engl J Med. 2024;391:1065.
    PubMed    


  11. AARON SD
    Early Diagnosis and Treatment of COPD and Asthma. Reply.
    N Engl J Med. 2024;391:968.
    PubMed    


  12. VAN GEFFEN WH, van der Meer AN
    Early Diagnosis and Treatment of COPD and Asthma.
    N Engl J Med. 2024;391:967-968.
    PubMed    


  13. YANG J, Liu W
    Angioedema of the Intestines.
    N Engl J Med. 2024;391:941.
    PubMed    


  14. JACKSON DJ, Wechsler ME, Jackson DJ, Bernstein D, et al
    Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype.
    N Engl J Med. 2024 Sep 9. doi: 10.1056/NEJMoa2406673.
    PubMed     Abstract available


    July 2024
  15. PETERS NE, Mac Lochlainn DJ, Dhalla F, Howarth L, et al
    Normalization of C1 Inhibitor in a Patient with Hereditary Angioedema.
    N Engl J Med. 2024;391:56-59.
    PubMed     Abstract available


  16. RIEDL MA, Farkas H, Aygoren-Pursun E, Psarros F, et al
    Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks.
    N Engl J Med. 2024;391:32-43.
    PubMed     Abstract available


  17. AMERATUNGA R, Longhurst HJ
    New Therapies for Type 1 and Type 2 Hereditary Angioedema.
    N Engl J Med. 2024;391:79-81.
    PubMed    


  18. RIEDL MA, Tachdjian R, Lumry WR, Craig T, et al
    Efficacy and Safety of Donidalorsen for Hereditary Angioedema.
    N Engl J Med. 2024;391:21-31.
    PubMed     Abstract available


    June 2024
  19. WRIGHT BL
    Unmasking the Culprits in Eosinophilic Esophagitis Pathogenesis.
    N Engl J Med. 2024;390:2321-2322.
    PubMed    


  20. ROTHENBERG ME, Dellon ES, Collins MH, Bredenoord AJ, et al
    Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis.
    N Engl J Med. 2024;390:2252-2263.
    PubMed     Abstract available


  21. CHEHADE M, Dellon ES, Spergel JM, Collins MH, et al
    Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age.
    N Engl J Med. 2024;390:2239-2251.
    PubMed     Abstract available


    May 2024
  22. WOOD RA, Togias A, Chinthrajah RS
    Omalizumab for the Treatment of Multiple Food Allergies. Reply.
    N Engl J Med. 2024;390:1936.
    PubMed    


  23. HUI SHI EN E, Cheng-Chung Wei J
    Omalizumab for the Treatment of Multiple Food Allergies.
    N Engl J Med. 2024;390:1936.
    PubMed    


  24. AARON SD, Vandemheen KL, Whitmore GA, Bergeron C, et al
    Early Diagnosis and Treatment of COPD and Asthma - A Randomized, Controlled Trial.
    N Engl J Med. 2024 May 19. doi: 10.1056/NEJMoa2401389.
    PubMed     Abstract available


  25. CHEN ST, Cochran RL, Jain S, Stagner AM, et al
    Case 15-2024: A 73-Year-Old Woman with Worsening Rash.
    N Engl J Med. 2024;390:1803-1813.
    PubMed    


    February 2024
  26. WANG S, Dai H
    Crazy-Paving Pattern in Pulmonary Sarcoidosis.
    N Engl J Med. 2024;390:e21.
    PubMed    


  27. WOOD RA, Togias A, Sicherer SH, Shreffler WG, et al
    Omalizumab for the Treatment of Multiple Food Allergies.
    N Engl J Med. 2024 Feb 25. doi: 10.1056/NEJMoa2312382.
    PubMed     Abstract available


  28. WONG GWK
    Options for Multiple Food Allergies - Food Avoidance or Pharmacologic Treatment?
    N Engl J Med. 2024 Feb 25. doi: 10.1056/NEJMe2400807.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.